Verition Fund Management
MGNX icon

Verition Fund Management’s MacroGenics MGNX Stock Holding History

Verition Fund Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-108,058
Closed -$137K – 3770
2025
Q1 		$137K Buy
+108,058
New +$282K ﹤0.01% 3119
2024
Q4 		– Sell
-90,304
Closed -$297K – 3404
2024
Q3 		$297K Buy
+90,304
New +$352K ﹤0.01% 2649
2021
Q2 		– Sell
-36,808
Closed -$1.17M – 2037
2021
Q1 		$1.17M Buy
+36,808
New +$894K 0.01% 559
2020
Q3 		– Sell
-10,546
Closed -$294K – 1261
2020
Q2 		$294K Buy
+10,546
New +$183K 0.01% 803
2018
Q4 		– Sell
-9,440
Closed -$202K – 1092
2018
Q3 		$202K Buy
+9,440
New +$201K 0.01% 1171

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Verition Fund Management's MGNX Position: Q2 2025 in Review

Verition Fund Management sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 108,058 shares — an estimated $137K sold.

Verition Fund Management first reported a position in MGNX in Q3 2018 and held it in 5 quarters. The position peaked at $1.17M in Q1 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Verition Fund Management reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 108,058 MacroGenics shares in Q2 2025, an estimated $137K.
  • Verition Fund Management first reported a position in MacroGenics in Q3 2018 and held it in 5 quarters.
  • Verition Fund Management's MacroGenics position peaked at $1.17M in Q1 2021.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.